Advanceconcept Pharmaceuticals Private Limited
About Advanceconcept Pharmaceuticals Private Limited
Data last updated:
Advanceconcept Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51900UP2014PTC061906. Its GSTIN is 09AAMCA4200D1Z4 (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shalini Maheshwari and Nandini Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 17 Deen Dayal Puram, Bareilly, Uttar Pradesh, India – 243001.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.3 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹12.69 Lakh (net margin 9.8%) and EBITDA of ₹17.16 Lakh (EBITDA margin 13.2%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Advanceconcept Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 17 Deen Dayal Puram, Bareilly, Uttar Pradesh, India – 243001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Advanceconcept Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Advanceconcept Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Advanceconcept Pharmaceuticals Private Limited, buy the company report.
Financials of Advanceconcept Pharmaceuticals Private Limited
FY 2025 filings availableAdvanceconcept Pharmaceuticals Private Limited reported revenue of ₹1.3 Cr (down 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 18% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.2% | ||||
| Net Profit Margin | 9.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Advanceconcept Pharmaceuticals Private Limited, buy the company report.
Board of directors of Advanceconcept Pharmaceuticals Private Limited
Advanceconcept Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalini Maheshwari | Director | 03 Apr 2014 | 12 Years 6 Months | Current |
| Nandini Gupta | Director | 10 Sep 2024 | 2 Years 1 Months | Current |
| Aryawardhan Gupta | Director | 10 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Advanceconcept Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M A Medifact Pharmaceuticals Private Limited | ₹1.3 Cr (FY 2016) | -11.0% | Delhi, India | |||
| Advanceconcept Pharmaceuticals Private Limitedthis company | ₹1.3 Cr (FY 2024) | ₹12.69 Lakh | 9.8% | -18.0% | 4 | Bareilly, Uttar Pradesh, India |
| Oro Pharmaceuticals Private Limited | ₹1.29 Cr (FY 2025) | -7.0% | Cuttack, Odisha, India | |||
| Biomi Life Sciences Private Limited | ₹1.29 Cr (FY 2024) | -45.0% | Chandrapur, Maharashtra, India | |||
| Bayonet Pharmaceuticals Private Limited | ₹1.29 Cr (FY 2025) | 12.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Advanceconcept Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Advanceconcept Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Advanceconcept Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Advanceconcept Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Advanceconcept Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Advanceconcept Pharmaceuticals Private Limited has a workforce of 4 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Advanceconcept Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCA4200D1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Advanceconcept Pharmaceuticals Private Limited, buy the company report.
Recent activity
Advanceconcept Pharmaceuticals Private Limited has 5 board changes on record since 2014: 4 appointments and 1 cessation. The latest: Aryawardhan Gupta was appointed as Director on 10 Sep 2024.
Frequently asked questions
Advanceconcept Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 January 2014 (12+ years old) and is registered under CIN U51900UP2014PTC061906.
Advanceconcept Pharmaceuticals has 3 current directors:
- Shalini Maheshwari - Director
- Nandini Gupta - Director
- Aryawardhan Gupta - Director
The latest financial statements of Advanceconcept Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Advanceconcept Pharmaceuticals is 09AAMCA4200D1Z4, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Advanceconcept Pharmaceuticals is U51900UP2014PTC061906. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Advanceconcept Pharmaceuticals was incorporated on 10 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Advanceconcept Pharmaceuticals by revenue are M A Medifact Pharmaceuticals Private Limited, Oro Pharmaceuticals Private Limited, Biomi Life Sciences Private Limited, Bayonet Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Aryawardhan Gupta was appointed as Director on 10 Sep 2024. Nandini Gupta was appointed as Director on 10 Sep 2024. Nishant Gupta ceased to be Director on 22 Apr 2024. Advanceconcept Pharmaceuticals has 5 board changes on record in total.
The registered office of Advanceconcept Pharmaceuticals is at C – 17 Deen Dayal Puram, Bareilly, Uttar Pradesh, India – 243001.
Advanceconcept Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Advanceconcept Pharmaceuticals is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.